Kistler Tiffany Companies, LLC Intercept Pharmaceuticals, Inc. Transaction History

Kistler Tiffany Companies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$24.48 - $42.47 $9,792 - $16,988	-400 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$57.36 - $124.1 $5,736 - $12,410	100 Added 33.33%	400 $50,000
Q1 2019 Apr 16, 2019	BUY	$91.83 - $120.68 $9,183 - $12,068	100 Added 50.0%	300 $34,000
Q4 2018 Jan 14, 2019	BUY	$85.79 - $126.46 $17,158 - $25,292	200 New	200 $20,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.